Cipla to Launch Ciplenza Next Month to Treat COVID-19 Patients in India
Mumbai: Cipla Limited today announced that it will commercially launch Ciplenza in the first week of August priced at Rs 68 per tablet for the treatment of COVID-19 patients in India.
In a statement, the company said that it has received…